Aspergillus species are the most frequent cause of fungal infections of the lungs with a
broad spectrum of clinical presentations including invasive pulmonary aspergillosis (IPA) …

Endemic fungal infections are responsible for high rates of morbidity and mortality in certain
regions of the world. The diagnosis and management remain a challenge, and the reason …

Background Chronic pulmonary aspergillosis has a 5-year mortality of 50–80% globally, and
the optimal duration of treatment for chronic pulmonary aspergillosis remains unclear. We …

Background Azole resistance complicates treatment of patients with invasive aspergillosis
with an increased mortality. Azole resistance in Aspergillus fumigatus is a growing problem …

Background The occurrence of chronic pulmonary aspergillosis (CPA) among drug sensitive
pulmonary tuberculosis (PTB) patients on optimal therapy with persistent symptoms was …

Background: The diagnosis of CPA relies on the detection of the IgG Aspergillus antibody,
which is not freely available, especially in resource-poor settings. Point-of-care tests like …

Chronic pulmonary aspergillosis (CPA) may mimic pulmonary tuberculosis (PTB). The two
diseases are clinically indistinguishable and may result in CPA misdiagnosed as PTB or …

Background Pulmonary tuberculosis (PTB) is a significant risk factor for fungal infection. The
cavitary lesions post PTB serves as a good reservoir for fungal colonization and subsequent …

Species within the Aspergillus spp. cause a wide range of infections in humans, including
invasive pulmonary aspergillosis, chronic pulmonary aspergillosis, and allergic …

Chronic pulmonary aspergillosis (CPA) is an uncommon but dreaded complication of many
respiratory diseases occurring in non-or mildly immunocompromised patients [1]. CPA …